Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.

Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.

One of the 20 or so human amyloid diseases is associated with the deposition in vital organs of full-length mutational variants of the antibacterial protein lysozyme. Here, we report experimental data that permit a detailed comparison to be made of the behaviour of two of these amyloidogenic variant...

Descripció completa

Dades bibliogràfiques
Autors principals:	Dumoulin, M, Canet, D, Last, A, Pardon, E, Archer, D, Muyldermans, S, Wyns, L, Matagne, A, Robinson, C, Redfield, C, Dobson, C
Format:	Journal article
Idioma:	English
Publicat:	2005

Ítems similars

Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme.
per: Canet, D, et al.
Publicat: (2002)

A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.
per: De Genst, E, et al.
Publicat: (2013)

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.
per: Dumoulin, M, et al.
Publicat: (2003)

The solution dynamics of amyloidogenic Asp67His variant of human lysozyme: Insights from hydrogen exchange
per: Canet, D, et al.
Publicat: (2000)

Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.
per: Canet, D, et al.
Publicat: (1999)

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.
per: Chan, P, et al.
Publicat: (2008)

Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy.
per: Chamberlain, A, et al.
Publicat: (2001)

Oxidative refolding of amyloidogenic variants of human lysozyme.
per: Wain, R, et al.
Publicat: (2005)

Investigation of non-covalent interactions of amyloidogenic human lysozyme variants and camelid antibodies
per: Caddy, G, et al.
Publicat: (2002)

Is lysozyme variant Thr70Asn amyloidogenic?
per: Booth, DR, et al.
Publicat: (2001)

Molecular Dynamics Study of Amyloidogenic Mutants of Human Lysozyme
per: Uliana Tarabara, et al.
Publicat: (2019-01-01)

Conformational dynamics and protein unfolding in lysozyme amyloidosis
per: Sunde, M, et al.
Publicat: (1999)

The origin of the alpha-domain intermediate in the folding of hen lysozyme.
per: Matagne, A, et al.
Publicat: (1998)

Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
per: Johnson, R, et al.
Publicat: (2005)

Structure of hen lysozyme in solution.
per: Smith, L, et al.
Publicat: (1993)

The significance of the location of mutations for the native-state dynamics of human lysozyme
per: Ahn, M, et al.
Publicat: (2016)

Thermal unfolding of an intermediate is associated with non-Arrhenius kinetics in the folding of hen lysozyme.
per: Matagne, A, et al.
Publicat: (2000)

Backbone 1H, 13C, and 15N resonance assignments for lysozyme from bacteriophage lambda.
per: Di Paolo, A, et al.
Publicat: (2010)

Backbone 1H, 13C, and 15N resonance assignments for lysozyme from bacteriophage lambda
per: Di Paolo, A, et al.
Publicat: (2010)

The dynamics of lysozyme from bacteriophage lambda in solution probed by NMR and MD simulations.
per: Smith, L, et al.
Publicat: (2013)

Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris.
per: Kumita, JR, et al.
Publicat: (2006)

Theoretical analysis of amyloidogenic potential of lysozyme, cytochrome C and apolipoprotein A-I
per: В. М. Трусова
Publicat: (2016-11-01)

Mutations in human prion-like domains: pathogenic but not always amyloidogenic
per: Andrea Bartolomé-Nafría, et al.
Publicat: (2024-12-01)

Rapid collapse into a molten globule is followed by simple two-state kinetics in the folding of lysozyme from bacteriophage λ.
per: Di Paolo, A, et al.
Publicat: (2010)

An NMR and MD study of complexes of bacteriophage lambda lysozyme with tetra- and hexa-n-acetylchitohexaose
per: Turupcu, A, et al.
Publicat: (2019)

The conformation of lysozyme in solution
per: Dobson, C, et al.
Publicat: (1975)

PRODUCTION OF N-15-LABELED HEN EGG-WHITE LYSOZYME USING ASPERGILLUS-NIGER
per: Roberts, I, et al.
Publicat: (1992)

Analysis of phi and chi 1 torsion angles for hen lysozyme in solution from 1H NMR spin-spin coupling constants.
per: Smith, L, et al.
Publicat: (1991)

The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.
per: Kumita, JR, et al.
Publicat: (2007)

Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry.
per: Nettleton, E, et al.
Publicat: (1998)

Kinetic consequences of the removal of a disulfide bridge on the folding of hen lysozyme.
per: Eyles, S, et al.
Publicat: (1994)

Characterisation of the dominant oxidative folding intermediate of hen lysozyme.
per: van den Berg, B, et al.
Publicat: (1999)

Cooperativity among short amyloid stretches in long amyloidogenic sequences.
per: Lele Hu, et al.
Publicat: (2012-01-01)

Probing conformations of amyloidogenic proteins by hydrogen exchange and mass spectrometry.
per: Nettleton, E, et al.
Publicat: (1999)

A refined solution structure of hen lysozyme determined using residual dipolar coupling data.
per: Schwalbe, H, et al.
Publicat: (2001)

Native-like secondary structure in a peptide from the alpha-domain of hen lysozyme.
per: Yang, J, et al.
Publicat: (1996)

Comparison of MD simulations and NMR experiments for hen lysozyme. Analysis of local fluctuations, cooperative motions, and global changes.
per: Smith, L, et al.
Publicat: (1995)

Site-specific hydrogen exchange of proteins: insights into the structures of amyloidogenic intermediates.
per: Yao, Z, et al.
Publicat: (2005)

The oxidative refolding of hen lysozyme and its catalysis by protein disulfide isomerase.
per: van den Berg, B, et al.
Publicat: (1999)

Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins
per: Antonella De Lillo, et al.
Publicat: (2024-03-01)